Shield Therapeutics PLC
OTC:SHIEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shield Therapeutics PLC
OTC:SHIEF
|
UK |
|
L
|
Latitude Group Holdings Ltd
ASX:LFS
|
AU |
|
H
|
House of Agriculture Spirou SA
ATHEX:SPIR
|
GR |
|
Y
|
Yeou Yih Steel Co Ltd
TPEX:9962
|
TW |
|
J
|
Johnson & Johnson
F:JNJ
|
US |
|
Maple Gold Mines Ltd
F:M3G0
|
CA |
|
F
|
Forcs Co Ltd
KOSDAQ:189690
|
KR |
|
G
|
Global Li-Ion Graphite Corp
CNSX:LION
|
CA |
|
N
|
Nomura Holdings Inc
XMUN:NSE
|
JP |
|
B
|
Blast Resources Inc
CNSX:BLST
|
CA |
|
Multi Indocitra Tbk PT
F:QF9
|
ID |
|
F
|
Fiserv Inc
LSE:0IP9
|
US |
|
A
|
American Water Works Company Inc
XMUN:AWC
|
US |
Bankruptcy Probability
Shield Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shield Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Shield Therapeutics PLC
LSE:STX
|
58.8m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
202.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
257.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shield Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shield Therapeutics PLC has total debt of 24.9m USD. This includes both short-term (0 USD) and long-term (24.9m USD) debt.
You can find a full breakdown on its Balance Sheet.